Transcutaneous Bilirubinometers Market to Reach USD 670 Million by 2031 Driven by Universal Neonatal Jaundice Screening and Portable Devices
[London, 28 July 2025] – The global transcutaneous bilirubinometers market is projected to grow from USD 0.29 billion in 2024 to USD 0.67 billion by 2031, with a CAGR of 12.7%, according to Clearview Market Insights (CVMI). Mandatory universal screening and increased investments in neonatal intensive care are boosting global demand.
Request Sample: https://clearviewmarketinsights.com/report-details/global-transcutaneous-bilirubinometers-market/
“Non-invasive bilirubin measurement is becoming the new standard in neonatal care, enabling earlier detection and reducing the burden on lab systems,” said Dr. Elena Huerta, Pediatric Diagnostics Analyst at CVMI.
Key OEMs driving this growth include Drägerwerk AG, Philips Healthcare, and Natus Medical, each advancing technologies in smart calibration, EHR integration, and connectivity. UNICEF and WHO are expanding access in under-resourced regions through public health deployments.
Recent milestones include the launch of Dräger’s Bilitest Neo with adaptive calibration, Philips’ AI-enabled jaundice alert tools, and Natus’ TCB 7000 handheld with Bluetooth. In Africa and Southeast Asia, low-cost solutions are expanding neonatal jaundice prevention.
For more insights, visit https://clearviewmarketinsights.com/
About Clearview Market Insights:
Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian